Identification of Serum CMTM2 as a Potential Biomarker for HBV-Related Disorders

Figure 3

Correlation between serum levels of CMTM2 and necroinflammation parameters. Correlation between serum CMTM2 levels and ALT levels in CHB (a), HBLC (b), and HCC (c) patients. Correlation between serum CMTM2 levels and AST levels in CHB (d), HBLC (e), and HCC (f) patients.

(a)

(b)

(c)

(d)

(e)

(f)